Peptris is an AI-powered preclinical drug discovery company, leveraging cutting-edge technology to accelerate the discovery of novel therapeutics.
Location: India
Total raised: $700M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 23.02.2026 | Series A | $700M | Speciale I... |
Mentions in press and media 7
| Date | Title | Description |
| 26.02.2026 | AI Biotech Peptris Secures $7.7 Million to Revolutionize Drug Discovery | Peptris, a Bengaluru-based AI drug discovery company, secured $7.7 million (Rs 70 crore) in Series A funding. This investment propels the expansion of its AI-led platform, accelerating novel molecule generation and advancing programs toward... |
| 23.02.2026 | Drug discovery platform Peptris raised Rs 70 Cr Series A funding | A Series A funding round led by IAN Alpha Fund and Speciale Invest, with participation from Tenacity Ventures, BYT Ventures, and other investors, has raised Rs 70 crore ($7.7 million) for the drug discovery company Peptris. According to a p... |
| 18.02.2026 | Peptris raises Rs 70 Cr in Series A funding co-led by IAN Alpha Fund, Speciale Invest | Peptris, a Bengaluru-based drug discovery company, has raised Rs 70 crore in a Series A funding round co-led by IAN Alpha Fund and Speciale Invest. The round also saw participation from Tenacity Ventures, BYT Ventures, and other investors. ... |
| 18.02.2026 | Statiq, Vervesemi, Peptris, others raise early-stage funding | Statiq co-founder and CEO Akshit Bansal (left) with co-founder and CTO Raghav Arora Electric vehicle charging platform Statiq, semiconductor company Vervesemi, AI drug discovery firm Peptris, nutraceuticals brand Zeroharm Sciences, asset ma... |
| 20.12.2023 | Deals in brief: Fikra Ace announces winners of accelerator program, Bayanat and Yahsat to merge into MENA’s space tech giant, multiple China and India deals, and more | Fikra Ace announces winners of its 2023 accelerator program To wrap up the 2023 edition of the Fikra Ace Accelerator program, a demo day was organized on November 9, 2023, by the Securities Commission Malaysia in collaboration with 1337 Ven... |
| 20.12.2023 | AI makes mark in drug discovery in India; start-up Peptris raises $1 mn | The process of discovering and developing a new drug can take decades and costs hundreds of millions or even billions of dollars. However, technological advances like artificial intelligence can help speed up and transform the time-consumin... |
| - | Peptris Technologies | “Peptris is an AI-powered preclinical drug discovery company, leveraging cutting-edge technology to accelerate the discovery of novel therapeutics.” |